CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 87,627 | ||
| 2025-12-05 | SHAROKY MELVIN MD Director | Sale | −20,000 | $205.01 | $4.1M | 243,948 |
| 2025-12-04 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,259 | $30.46 | $191K | 310,170 |
| 2025-12-04 | Lewis William Chair and CEO | Option exercise 10b5-1 | +4,440 | $17.16 | $76K | 314,610 |
| 2025-12-04 | Lewis William Chair and CEO | Sale 10b5-1 | −4,516 | $204.62 | $924K | 310,094 |
| 2025-12-04 | Lewis William Chair and CEO | Sale 10b5-1 | −2,222 | $205.66 | $457K | 307,872 |
| 2025-12-04 | Lewis William Chair and CEO | Sale 10b5-1 | −2,921 | $206.49 | $603K | 304,951 |
| 2025-12-04 | Lewis William Chair and CEO | Sale 10b5-1 | −1,040 | $207.42 | $216K | 303,911 |
| 2025-12-04 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 93,886 | ||
| 2025-12-04 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 66,600 | ||
| 2025-12-01 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +8,895 | $25.83 | $230K | 92,006 |
| 2025-12-01 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,450 | $205.98 | $299K | 90,556 |
| 2025-12-01 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −5,886 | $207.03 | $1.2M | 84,670 |
| 2025-12-01 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −1,559 | $207.73 | $324K | 83,111 |
| 2025-12-01 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,895 | 44,475 | ||
| 2025-11-24 | ANDERSON ELIZABETH M Director | Sale | −5,000 | $204.58 | $1.0M | 58,729 |
| 2025-11-17 | LEE LEO Director | Sale | −3,212 | $193.51 | $622K | 126,465 |
| 2025-11-17 | LEE LEO Director | Sale | −17,594 | $194.49 | $3.4M | 108,871 |
| 2025-11-17 | LEE LEO Director | Sale | −14,944 | $195.39 | $2.9M | 93,927 |
| 2025-11-17 | LEE LEO Director | Sale | −24,076 | $196.61 | $4.7M | 69,851 |
Page 14 of 23 · 448 trades